Table 3.
Effect of mGlu2 mutations on NAM inhibition of LY354740-induced intracellular Ca2+ release
RO4988546 | RO5488608 | ||||||
---|---|---|---|---|---|---|---|
Mutant | Position | IC50 (nM) | Ratio vs. WT | nH | IC50 (nM) | Ratio vs. WT | nH |
WT | 5.5 ± 0.5 | −2.0 ± 0.2 | 11.4 ± 1.1 | −2.4 ± 0.8 | |||
C616S | 2.57 | 5.3 ± 0.7 | 1.0 | −2.4 ± 0.6 | 8.9 ± 1.4 | 0.8 | −1.8 ± 0.5 |
Y617F | 2.58 | 7.2 ± 0.8 | 1.3 | −1.5 ± 0.2 | 12.3 ± 4.1 | 1.1 | −1.6 ± 0.2 |
T620A | 2.61 | 4.4 ± 0.7 | 0.8 | −1.7 ± 0.3 | 11.8 ± 1.8 | 1.0 | −1.7 ± 0.3 |
R635A | 3.28 | 83.5 ± 20.6 | 15.2 | −1.7 ± 0.2 | 26.7 ± 6.8 | 2.3 | −1.8 ± 0.4 |
R636A | 3.29 | 22.8 ± 1.5 | 4.1 | −1.0 ± 0.2 | >1000 | >100 | |
L639A | 3.32 | 6.6 ± 1.5 | 1.2 | −1.5 ± 0.2 | 19.9 ± 4.6 | 1.7 | −1.3 ± 0.3 |
A642S | 3.35 | 5.8 ± 1.4 | 1.1 | −1.8 ± 0.1 | 18.0 ± 2.6 | 1.6 | −2.3 ± 0.2 |
F643A | 3.36 | 106.4 ± 21.0 | 19.3 | −1.3 ± 0.2 | 13.6 ± 3.1 | 1.2 | −2.0 ± 0.5 |
S644A | 3.37 | 4.9 ± 1.2 | 0.9 | −1.9 ± 0.2 | 12.9 ± 2.9 | 1.1 | −2.0 ± 0.1 |
Y647V | 3.40 | 15.8 ± 8.2 | 2.9 | −1.2 ± 0.3 | 9.5 ± 2.8 | 0.8 | −2.2 ± 0.4 |
S688L-G689V | 4.44–45 | 11.5 ± 1.9 | 2.1 | −1.8 ± 0.2 | 26.7 ± 4.2 | 2.3 | −4.5 ± 0.4 |
H723F | E2.52 | 15.9 ± 4.1 | 2.9 | −1.4 ± 0.1 | 322.2 ± 175.5 | 28.3 | −0.9 ± 0.1 |
H723V | E2.52 | 45.2 ± 8.0 | 8.2 | −1.0 ± 0.2 | 93.3 ± 23.3 | 8.2 | −1.0 ± 0.1 |
M728A | 5.39 | 1.8 ± 0.4 | 0.3 | −2.3 ± 0.5 | 3.5 ± 0.1 | 0.3 | −2.5 ± 0.3 |
S731A | 5.42 | 3.9 ± 0.3 | 0.7 | −2.1 ± 0.2 | 10.9 ± 2.1 | 0.9 | −2.1 ± 0.3 |
L732A | 5.43 | 50.0 ± 11.8 | 9.1 | −1.0 ± 0.1 | 348.9 ± 39.1 | 30.6 | −1.0 ± 0.2 |
N735D | 5.46 | 7.6 ± 1.1 | 1.4 | −1.9 ± 0.3 | 14.5 ± 3.0 | 1.3 | −1.9 ± 0.2 |
V736A | 5.47 | 2.7 ± 0.4 | 0.5 | −1.8 ± 0.3 | 5.3 ± 0.7 | 0.5 | −1.8 ± 0.2 |
T769S | 6.44 | 2.3 ± 0.5 | 0.4 | −1.8 ± 0.1 | 10.1 ± 3.0 | 0.9 | −2.6 ± 0.6 |
T769V | 6.44 | 2.7 ± 0.6 | 0.5 | −1.9 ± 0.03 | 9.5 ± 1.7 | 0.8 | −2.0 ± 0.2 |
W773F | 6.48 | 62.8 ± 11.9 | 11.4 | −1.1 ± 0.1 | 21.2 ± 4.2 | 1.9 | −1.5 ± 0.4 |
W773A | 6.48 | 984.1 ± 232.9 | 178.9 | −1.3 ± 0.6 | x | ||
L777A | 6.52 | 4.9 ± 0.4 | 0.9 | −1.9 ± 0.6 | 10.9 ± 1.8 | 1.0 | −1.3 ± 0.1 |
F780A | 6.55 | 43.7 ± 11.2 | 7.9 | −1.2 ± 0.1 | 9.0 ± 2.6 | 0.8 | −1.2 ± 0.2 |
T793A | 7.38 | 5.2 ± 1.0 | 0.9 | −1.6 ± 0.1 | 10.0 ± 1.4 | 0.9 | −1.8 ± 0.2 |
M794A | 7.39 | 3.9 ± 1.2 | 0.7 | −1.6 ± 0.1 | 12.4 ± 2.2 | 1.1 | −2.1 ± 0.4 |
C795A | 7.40 | 3.4 ± 0.4 | 0.6 | −1.8 ± 0.1 | 13.2 ± 3.4 | 1.2 | −2.4 ± 0.7 |
S797A | 7.42 | 7.0 ± 1.7 | 1.3 | −1.5 ± 0.1 | 17.4 ± 3.2 | 1.5 | −2.7 ± 0.2 |
V798A | 7.43 | 8.1 ± 1.2 | 1.5 | −1.8 ± 0.1 | 62.7 ± 11.4 | 5.5 | −2.4 ± 0.3 |
The IC50 value, ratio versus WT and Hill coefficient of RO4988546 and RO5488608 inhibition of LY354740-induced Ca2+ release on mGlu2 WT and mutant receptors after transient transfection into CHO-Gα16 cells. Affected mutants are shown in bold. Data are presented as mean ± SEM and for RO4988546 the calculated values represent three to eight dose–response measurements from three to eight independent transfections and for RO5488608 the values represent three to five dose–response measurements from three to four independent transfections.